Trials / Completed
CompletedNCT03814915
Diabetes Research on Patient Stratification
DIabetes REsearCh on Patient straTification
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 3,049 (actual)
- Sponsor
- Lund University · Academic / Other
- Sex
- All
- Age
- 35 Years – 74 Years
- Healthy volunteers
- Not accepted
Summary
The overarching goal of the IMI DIRECT (Innovative Medicines Initiative Diabetes Research on Patient Stratification) Consortium is the identification of biomarkers that aid therapeutic targeting in prediabetes (Study 1) or early onset type 2 diabetes (Study 2).
Detailed description
There are two multicentre prospective cohort studies within the glycaemic deterioration work package of IMI DIRECT (WP2). These two cohorts are designed to address the area of glycaemic deterioration by amassing data and biomaterials that will be used to discover novel biomarkers for glycaemic deterioration in people at high risk of developing type 2 diabetes (Study 1) and in those who have recently been diagnosed with the disease (Study 2).
Conditions
Timeline
- Start date
- 2012-10-15
- Primary completion
- 2019-07-31
- Completion
- 2019-07-31
- First posted
- 2019-01-24
- Last updated
- 2020-01-18
Source: ClinicalTrials.gov record NCT03814915. Inclusion in this directory is not an endorsement.